AAN.com
Quick search in Citations
AnywhereCitation
Advanced Search
Trending Terms:
Articles
October 8, 2007

Medical decision-making capacity in patients with mild cognitive impairment

O. Okonkwo, MA, H. R. Griffith, PhD, K. Belue, BS, S. Lanza, BS, E. Y. Zamrini, MD, L. E. Harrell, MD, PhD, J. C. Brockington, MD, D. Clark, MD, R. Raman, PhD, and D. C. Marson, JD, PhDAuthors Info & Affiliations
October 9, 2007 issue
69 (15) 1528-1535
https://doi.org/10.1212/01.wnl.0000277639.90611.d9
Letters to the Editor
Track CitationsAdd to favorites
Get Access

Abstract

Objectives: To empirically assess the capacity of patients with amnestic mild cognitive impairment (MCI) to consent to medical treatment under different consent standards (Ss).
Methods: Participants were 56 healthy controls, 60 patients with MCI, and 31 patients with mild Alzheimer disease (AD). Each participant was administered the Capacity to Consent to Treatment Instrument (CCTI) and a comprehensive neuropsychological battery. Group differences in performance on the CCTI and neuropsychological variables were examined. In addition, the capacity status (capable, marginally capable, or incapable) of each MCI participant on each CCTI standard was examined using cut scores derived from control performance.
Results: Patients with MCI performed comparably to controls on minimal consent standards requiring merely expressing a treatment choice (S1) or making the reasonable treatment choice [S2], but significantly below controls on the three clinically relevant standards of appreciation (S3), reasoning (S4), and understanding (S5). In turn, the MCI group performed significantly better than the mild AD group on [S2], S4, and S5. Regarding capacity status, patients with MCI showed a progressive pattern of capacity compromise (marginally capable and incapable outcomes) related to stringency of consent standard.
Conclusions: Patients with amnestic mild cognitive impairment (MCI) demonstrate significant impairments on clinically relevant abilities associated with capacity to consent to treatment. In obtaining informed consent, clinicians and researchers working with patients with MCI must consider the likelihood that many of these patients may have impairments in consent capacity related to their amnestic disorder and related cognitive impairments.
GLOSSARY: AD = Alzheimer disease; ADRC = Alzheimer's Disease Research Center; CCTI = Capacity to Consent to Treatment Instrument; CVLT-II = California Verbal Learning Test, second edition; DRS-2 = Dementia Rating Scale, 2nd edition; GDS = Geriatric Depression Scale; MCI = mild cognitive impairment; MDC = medical decision-making capacity; MMSE = Mini-Mental State Examination; Ss = consent standards; WAIS-III = Wechsler Adult Intelligence Scale, third edition; WMS-III = Wechsler Memory Scale, third edition; WMS-R = Wechsler Memory Scale, revised edition; WRAT-3 = Wide Range Achievement Test, third edition.

Get full access to this article

View all available purchase options and get full access to this article.

Get Access

REFERENCES

1.
Marson DC, Ingram K, Cody H, Harrell LE. Assessing the competency of patients with Alzheimer's disease under different legal standards. Arch Neurol 1995;52:949–954.
Crossref
PubMed
Google Scholar
2.
Grisso T. Evaluating competencies: Forensic assessments and instruments. New York: Plenum Press; 1986.
Google Scholar
3.
Kim SYH, Karlawish JHT. Ethics and politics of research involving subjects with impaired decision-making abilities. Neurology 2003;62:1645–1646.
Google Scholar
4.
Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005;62:1160–1163.
Crossref
PubMed
Google Scholar
5.
Burns A, Zaudig M. Mild cognitive impairment in older people. Lancet 2002;360:1963–1965.
Crossref
PubMed
Google Scholar
6.
Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379–2388.
Crossref
PubMed
Google Scholar
7.
Moye J, Karel MJ, Azar AR, Gurrera RJ. Capacity to consent to treatment: Empirical comparison of three instruments in older adults with and without dementia. Gerontologist 2004;44:166–175.
Crossref
PubMed
Google Scholar
8.
Karlawish JHT, Casarett DJ, James BD, Xie SX, Kim SYH. The ability of persons with Alzheimer's disease (AD) to make a decision about taking an AD treatment. Neurology 2005;64:1514–1519.
Crossref
PubMed
Google Scholar
9.
Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992.
Crossref
PubMed
Google Scholar
10.
Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. Lancet 2006;367:1262–1270.
Crossref
PubMed
Google Scholar
11.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–944.
Crossref
PubMed
Google Scholar
12.
Griffith HR, Dymek MP, Atchison P, Harrell LE, Marson DC. Medical decision-making in neurodegenerative disease: mild AD and PD with cognitive impairment. Neurology 2005;65:483–485.
Crossref
PubMed
Google Scholar
13.
Dymek MP, Marson DC, Harrell LE. Factor structure of capacity to consent to medical treatment in patients with Alzheimer's disease: an exploratory study. J Forens Neuropsychol 1999;1:27–48.
Google Scholar
14.
Marson DC, Chatterjee A, Ingram K, Harrell LE. Towards a neurologic model of competency: cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards. Neurology 1996;46:666–672.
Crossref
PubMed
Google Scholar
15.
Tepper A, Elwork A. Competency to consent to treatment as a psycholegal construct. Law and Human Behavior 1984;8:205–223.
PubMed
Google Scholar
16.
Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. 4th ed. New York: Oxford University Press; 2004.
Google Scholar
17.
Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98.
Crossref
PubMed
Google Scholar
18.
Jurica PJ, Leitten CL, Mattis S. Dementia Rating Scale. 2nd ed. Lutz, FL: Psychological Assessment Resources; 2001.
Google Scholar
19.
Wechsler D. Wechsler Memory Scale–Revised edition. San Antonio: Psychological Corporation; 1987.
Google Scholar
20.
Wechsler D. WMS-III: Wechsler Memory Scale–3rd edition. San Antonio: Psychological Corporation; 1997.
Google Scholar
21.
Kaplan E, Goodglass H, Weintraub S. Boston Naming Test. Philadelphia: Lea & Febiger; 1983.
Google Scholar
22.
Spreen O, Strauss E. A compendium of neuropsychological tests. New York: Oxford University Press; 1991.
Google Scholar
23.
Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test. 2nd ed. San Antonio: Psychological Corporation; 2000.
Google Scholar
24.
Royall DR, Cordes JA, Polk M. CLOX: An executive clock-drawing task. J Neurol Neurosurg Psychiatry 1998;64:588–594.
Crossref
PubMed
Google Scholar
25.
Wang PL, Ennis KE. The cognitive competency test. Toronto: Mt. Sinai Hospital Neuropsychology Laboratory; 1986.
Google Scholar
26.
Reitan R, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and clinical interpretation. Tucson: Neuropsychology Press; 1993.
Google Scholar
27.
Wechsler D. WAIS-III: Wechsler Adult Intelligence Scale–3rd edition. San Antonio: The Psychological Corporation; 1997.
Google Scholar
28.
Wilkinson G. Wide Range Achievement Test Administration Manual. 3rd ed. Wilmington, DE: Wide Range Incorporated; 1993.
Google Scholar
29.
Yesavage J. Geriatric depression scale. Psychopharmacol Bull 1988;24:709–713.
PubMed
Google Scholar
30.
Nygard L. Instrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment? Acta Neurol Scand 2003;107(suppl 179):42–46.
Crossref
PubMed
Google Scholar
31.
Griffith HR, Belue K, Sicola A, et al. Impaired financial abilities in mild cognitive impairment. Neurology 2003;60:449–457.
Crossref
PubMed
Google Scholar
32.
Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994;44:1427–1432.
Crossref
PubMed
Google Scholar
33.
Ganguli M, Dodge HH, Shen C, DeKosky ST. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004;63:115–121.
Crossref
PubMed
Google Scholar
34.
Mello MM, Studdert D, Brennan TA. The rise of litigation in human subjects research. Ann Intern Med 2003;139:40–45.
Crossref
PubMed
Google Scholar
35.
Grisso T, Appelbaum PS. Mentally ill and non-mentally ill patients' abilities to understand informed consent disclosure for medication. Law Hum Behav 1991;15:377–388.
Crossref
PubMed
Google Scholar
36.
Taub H, Kline G, Baker M. The elderly and informed consent: Effects of vocabulary level and corrected feedback. Exp Aging Res 1991;17:137–146.
Google Scholar
37.
Mittal D, Palmer B, Dunn L, et al. Comparison of two enhanced consent procedures for patients with mild Alzheimer disease or mild cognitive impairment. American Journal of Geriatric Psychiatry 2007;15:163–167.
Crossref
PubMed
Google Scholar
38.
Fitten LJ, Lusky R, Hamann C. Assessing treatment decision-making capacity in elderly nursing home residents. J Am Geriatr Soc 1990;38:1097–1104.
Crossref
PubMed
Google Scholar

Information & Authors

Information

Published In

Neurology®
Volume 69 • Number 15 • October 9, 2007
Pages: 1528-1535
PubMed: 17923615

Copyright

© 2007.

Publication History

Published online: October 8, 2007
Published in print: October 9, 2007

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

O. Okonkwo, MA
From the Departments of Psychology (O.O.) and Neurology (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.) and Alzheimer's Disease Research Center (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.), University of Alabama at Birmingham; Veterans Administration Medical Center (L.E.H., D.C.), Birmingham, AL; Department of Neurology (E.Y.Z.), University of Utah Health Sciences, Salt Lake City; and Department of Family and Preventive Medicine and Neurosciences (R.R.), University of California San Diego.
View all articles by this author
H. R. Griffith, PhD
From the Departments of Psychology (O.O.) and Neurology (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.) and Alzheimer's Disease Research Center (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.), University of Alabama at Birmingham; Veterans Administration Medical Center (L.E.H., D.C.), Birmingham, AL; Department of Neurology (E.Y.Z.), University of Utah Health Sciences, Salt Lake City; and Department of Family and Preventive Medicine and Neurosciences (R.R.), University of California San Diego.
View all articles by this author
K. Belue, BS
From the Departments of Psychology (O.O.) and Neurology (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.) and Alzheimer's Disease Research Center (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.), University of Alabama at Birmingham; Veterans Administration Medical Center (L.E.H., D.C.), Birmingham, AL; Department of Neurology (E.Y.Z.), University of Utah Health Sciences, Salt Lake City; and Department of Family and Preventive Medicine and Neurosciences (R.R.), University of California San Diego.
View all articles by this author
S. Lanza, BS
From the Departments of Psychology (O.O.) and Neurology (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.) and Alzheimer's Disease Research Center (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.), University of Alabama at Birmingham; Veterans Administration Medical Center (L.E.H., D.C.), Birmingham, AL; Department of Neurology (E.Y.Z.), University of Utah Health Sciences, Salt Lake City; and Department of Family and Preventive Medicine and Neurosciences (R.R.), University of California San Diego.
View all articles by this author
E. Y. Zamrini, MD
From the Departments of Psychology (O.O.) and Neurology (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.) and Alzheimer's Disease Research Center (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.), University of Alabama at Birmingham; Veterans Administration Medical Center (L.E.H., D.C.), Birmingham, AL; Department of Neurology (E.Y.Z.), University of Utah Health Sciences, Salt Lake City; and Department of Family and Preventive Medicine and Neurosciences (R.R.), University of California San Diego.
View all articles by this author
L. E. Harrell, MD, PhD
From the Departments of Psychology (O.O.) and Neurology (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.) and Alzheimer's Disease Research Center (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.), University of Alabama at Birmingham; Veterans Administration Medical Center (L.E.H., D.C.), Birmingham, AL; Department of Neurology (E.Y.Z.), University of Utah Health Sciences, Salt Lake City; and Department of Family and Preventive Medicine and Neurosciences (R.R.), University of California San Diego.
View all articles by this author
J. C. Brockington, MD
From the Departments of Psychology (O.O.) and Neurology (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.) and Alzheimer's Disease Research Center (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.), University of Alabama at Birmingham; Veterans Administration Medical Center (L.E.H., D.C.), Birmingham, AL; Department of Neurology (E.Y.Z.), University of Utah Health Sciences, Salt Lake City; and Department of Family and Preventive Medicine and Neurosciences (R.R.), University of California San Diego.
View all articles by this author
D. Clark, MD
From the Departments of Psychology (O.O.) and Neurology (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.) and Alzheimer's Disease Research Center (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.), University of Alabama at Birmingham; Veterans Administration Medical Center (L.E.H., D.C.), Birmingham, AL; Department of Neurology (E.Y.Z.), University of Utah Health Sciences, Salt Lake City; and Department of Family and Preventive Medicine and Neurosciences (R.R.), University of California San Diego.
View all articles by this author
R. Raman, PhD
From the Departments of Psychology (O.O.) and Neurology (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.) and Alzheimer's Disease Research Center (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.), University of Alabama at Birmingham; Veterans Administration Medical Center (L.E.H., D.C.), Birmingham, AL; Department of Neurology (E.Y.Z.), University of Utah Health Sciences, Salt Lake City; and Department of Family and Preventive Medicine and Neurosciences (R.R.), University of California San Diego.
View all articles by this author
D. C. Marson, JD, PhD
From the Departments of Psychology (O.O.) and Neurology (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.) and Alzheimer's Disease Research Center (H.R.G., K.B., S.L., L.E.H., J.C.B., D.C., D.C.M.), University of Alabama at Birmingham; Veterans Administration Medical Center (L.E.H., D.C.), Birmingham, AL; Department of Neurology (E.Y.Z.), University of Utah Health Sciences, Salt Lake City; and Department of Family and Preventive Medicine and Neurosciences (R.R.), University of California San Diego.
View all articles by this author

Notes

Address correspondence and reprint requests to Dr. Daniel Marson, Department of Neurology, JT 1216, University of Alabama at Birmingham, Birmingham, AL 35233-7340 [email protected].

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
    • Ilaria Corbo,
    • Francesca Favieri,
    • Giuseppe Forte,
    • Maria Casagrande,
    Decision-making under uncertainty in healthy and cognitively impaired aging: A systematic review and meta-analysis, Archives of Gerontology and Geriatrics, 129, (105643), (2025).https://doi.org/10.1016/j.archger.2024.105643
    Crossref
    • Federica Alfeo,
    • Tiziana Lanciano,
    • Chiara Abbatantuono,
    • Giorgia Gintili,
    • Maria Fara De Caro,
    • Antonietta Curci,
    • Paolo Taurisano,
    Cognitive, Emotional, and Daily Functioning Domains Involved in Decision-Making among Patients with Mild Cognitive Impairment: A Systematic Review, Brain Sciences, 14, 3, (278), (2024).https://doi.org/10.3390/brainsci14030278
    Crossref
    • Md Atik Enam,
    • Ananta Bastola,
    • Julian Brinkley,
    An Inclusive Model for External Human Machine Interfaces of Autonomous Vehicles, 2024 IEEE 4th International Conference on Human-Machine Systems (ICHMS), (1-6), (2024).https://doi.org/10.1109/ICHMS59971.2024.10555718
    Crossref
    • Jeffrey C. Zemla,
    Increased reliance on heuristic thinking in mild cognitive impairment, Aging, Neuropsychology, and Cognition, (1-16), (2024).https://doi.org/10.1080/13825585.2024.2405506
    Crossref
    • Laura Fenton,
    • S. Duke Han,
    • Carolyn G. DiGuiseppi,
    • Nicole R. Fowler,
    • Linda Hill,
    • Rachel L. Johnson,
    • Ryan A. Peterson,
    • Christopher E. Knoepke,
    • Daniel D. Matlock,
    • Ryan Moran,
    • Jason Karlawish,
    • Marian E. Betz,
    Mild Cognitive Impairment is Associated with Poorer Everyday Decision Making, Journal of Alzheimer's Disease, 94, 4, (1607-1615), (2023).https://doi.org/10.3233/JAD-230222
    Crossref
    • Andrea M. Mejia,
    • Glenn E. Smith,
    • Meredith Wicklund,
    • Melissa J. Armstrong,
    Shared decision making in mild cognitive impairment, Neurology Clinical Practice, 9, 2, (160-164), (2023)./doi/10.1212/CPJ.0000000000000576
    Abstract
    • Francesco Patti,
    • Clara Grazia Chisari,
    • Simona Toscano,
    • Pietro Annovazzi,
    • Paola Banfi,
    • Roberto Bergamaschi,
    • Raffaella Clerici,
    • Marta Zaffira Conti,
    • Antonio Cortese,
    • Roberta Fantozzi,
    • Diana Ferraro,
    • Mariano Fischetti,
    • Maura Frigo,
    • Maurizia Gatto,
    • Paolo Immovilli,
    • Stefania Leoni,
    • Simona Malucchi,
    • Giorgia Maniscalco,
    • Girolama Alessandra Marfia,
    • Damiano Paolicelli,
    • Paola Perini,
    • Carlo Serrati,
    • Rocco Totaro,
    • Gabriella Turano,
    • Paola Valentino,
    • Mauro Zaffaroni,
    • Cristina Zuliani,
    • Diego Centonze,
    Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study, Multiple Sclerosis and Related Disorders, 70, (104474), (2023).https://doi.org/10.1016/j.msard.2022.104474
    Crossref
    • Ana Saraiva Amaral,
    • Mário Rodrigues Simões,
    • Sandra Freitas,
    • Rosa Marina Afonso,
    Development of clinical vignettes to assess healthcare decision-making capacity in elderly with mild cognitive impairment and Alzheimer's disease, European Review of Applied Psychology, 73, 3, (100799), (2023).https://doi.org/10.1016/j.erap.2022.100799
    Crossref
    • Natália Araújo,
    • Adriana Costa,
    • Catarina Lopes,
    • Luisa Lopes-Conceição,
    • Augusto Ferreira,
    • Filipa Carneiro,
    • Jorge Oliveira,
    • Samantha Morais,
    • Luís Pacheco-Figueiredo,
    • Luis Ruano,
    • Vítor Tedim Cruz,
    • Susana Pereira,
    • Nuno Lunet,
    Prevalence of Cognitive Impairment before Prostate Cancer Treatment, Cancers, 14, 5, (1355), (2022).https://doi.org/10.3390/cancers14051355
    Crossref
    • Raquel Luiza Santos,
    • José Pedro Simões Neto,
    • Tatiana Belfort,
    • Isabel Barbeito Lacerda,
    • Marcia Cristina Nascimento Dourado,
    Patterns of impairment in decision-making capacity in Alzheimer’s disease and its relationship with cognitive and clinical variables, Brazilian Journal of Psychiatry, 44, 3, (271-278), (2022).https://doi.org/10.1590/1516-4446-2021-2180
    Crossref
  11. See more

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share

View full text|Download PDF